Altergon Italia

Altergon Italia is an Italian pharmaceutical and biotechnology company focused on innovation in drug delivery and the production of high-purity hyaluronic acid. It combines scientific research and development with manufacturing services, supporting pharmaceutical and medical-sector clients as a Contract Development and Manufacturing Organization (CDMO). Its offerings include medicated patches and transdermal drug-in-adhesive systems, hydrogel formulations, and the SHYALT® Ultrapure sodium hyaluronate product.

The company also provides contract manufacturing of orodispersible films, sterile prefilled syringes, and medical devices, alongside secondary packaging, pharmaceutical warehousing, quality-control analysis, and Qualified Person batch release services. Altergon is developing microneedle technology for transdermal delivery of active ingredients. Its capabilities extend to biotechnological hyaluronic acid production and specialized pharmaceutical manufacturing.

The company emphasizes regulatory standards, ethical production, product safety, and ongoing innovation. Its research initiatives include development of crosslinked glycosaminoglycan-based injectable fillers for biomedical and dermo-aesthetic applications. Through its products, services, and development partnerships, Altergon aims to provide modern, high-quality solutions for evolving pharmaceutical and medical needs